Azitra, Inc. (NYSEAMERICAN:AZTR) Stock Short Interest Climbs 172.3%

Azitra, Inc. (NYSEAMERICAN:AZTR) was the target of a significant increase in short interest in the month of October. As of October 30th, there was short interest totaling 305,802 shares, an increase of 172.3% from the October 15th total of 112,293 shares. Based on an average daily volume of 14,623,589 shares, the days-to-cover ratio is presently 0.0 days. Approximately 5.1% of the company’s stock are sold short.

Azitra Stock Performance

Shares of AZTR stock opened at $0.67 on Friday. Azitra has a fifty-two week low of $0.52 and a fifty-two week high of $4.30. The company has a 50 day moving average price of $1.72 and a 200 day moving average price of $1.86.

Azitra (NYSEAMERICAN:AZTR) last released its earnings results on Thursday, November 12th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.25) by ($0.04). On average, equities analysts predict that Azitra will post -2.05 earnings per share for the current year.

Azitra Company Profile

Azitra, Inc. is a clinical-stage biotechnology company focused on developing microbiome-based therapies for dermatological conditions. The company combines microbiology, genetic engineering and computational tools to identify and develop targeted treatments intended to address diseases affecting the skin. Azitra’s platform centers on engineered strains of beneficial skin bacteria and biologic compounds designed to deliver therapeutic proteins or otherwise influence the skin’s local environment. Its development programs have focused on conditions including inflammatory skin disorders, rare genetic diseases and treatment-related dermatologic complications.